Beijing Targets Five Pharmaceutical Products Exceeding US$1 Billion in Annual Global Sales
According to the South China Morning Post, Beijing is aiming for at least five pharmaceutical products to achieve annual global sales surpassing US$1 billion, a target some analysts suggest is attainable based on current trends.
)
The South China Morning Post reports that Beijing is striving to have a minimum of five pharmaceutical items generating annual worldwide sales exceeding US$1 billion. Some analysts suggest this objective is within reach. Cui Cui, who serves as the head of Asia healthcare research at Jefferies, observed that Chinese biopharmaceutical firms accounted for more than 50 per cent of the total global deal value during the first half of 2026, asserting that their "competitive efficiency and speed" would propel global commercialization. Furthermore, Julia Pian, a senior associate at Atlas Venture, stated in a blog post from the previous week that the measurable objectives established in China's five-year plan were "well within reach" when considering the present trajectory.
)
)
)